SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock is facing significant downward pressure following an earnings report that highlighted a weak outlook and slower-than-expected turnaround in the China market, triggering a wave of analyst downgrades. Community discussion is heavily polarized between investors betting on a long-term 'buy the dip' opportunity for an iconic brand and those warning of a structural decline due to increased competition and shifting consumer preferences.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly (LLY) is trending following an FDA warning against telehealth companies for misleading marketing of compounded GLP-1 medications, a move that clarifies market expectations and increases regulatory scrutiny on the weight-loss drug space. The community is actively debating the stock's valuation, the long-term impact of potential pricing pressures, and the highly anticipated upcoming FDA approval for the company's oral obesity pill, orforglipron.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is capturing significant attention as investors speculate on upcoming cannabis rescheduling news and federal pilot programs, with sentiment sharply divided between those betting on a short squeeze and critics pointing to the company's fiscal history and management. The stock remains a high-volatility battleground where community discussions are currently fixated on potential catalysts like shifting FDA policies and the implications of the company's upcoming earnings release.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as the company receives FDA approval for a higher-dose version of Wegovy, a move aimed at boosting efficacy and strengthening its competitive standing in the GLP-1 weight-loss market. The community is actively debating the stock's long-term potential, with bulls pointing to the new FDA milestone and a robust pipeline, while others remain skeptical due to pricing pressures, intense competition from Eli Lilly, and recent volatility in the broader pharmaceutical sector.

RH operates as a holding company which operates the business through its subsidiary Restoration Hardware, Inc. It offers furniture, lighting, textiles, bath ware, decor, outdoor and garden, as well as baby and child products. The company operates an integrated business with multiple channels of distribution including galleries, source books and websites. The company was founded by Stephen J. Gordon in 1980 and is headquartered in Corte Madera, CA.

RH - Ordinary Shares - Class A

Restoration Hardware

Restoration Hardware (RH) is experiencing extreme volatility as investors weigh the impact of ongoing tariff headwinds and a struggling housing market against the potential for a short squeeze. Market participants are heavily focused on the company's mixed earnings results and management's guidance, while the community remains sharply divided over the long-term viability of their luxury retail model in a high-interest rate environment.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending as investors weigh its aggressive foundry expansion and capital structure moves against broader macroeconomic uncertainty driven by rising oil prices and geopolitical instability. The community remains deeply divided, with bulls pointing to the company's long-term manufacturing roadmap and potential for major customer announcements, while bears are focused on the stock's recent price volatility and sensitivity to regional tensions.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is attracting heavy retail attention as traders speculate on a potential short squeeze, citing its history as a volatile, low-float runner and tight share structure. While the community is sharply divided between bullish expectations of a parabolic move and warnings of a pump-and-dump scheme, discussions remain intensely focused on cost-to-borrow data and the stock's tendency for rapid, high-volume spikes.

SharonAI Holdings, Inc. engages in providing high-performance computing (HPC), artificial intelligence (AI), and cloud GPU compute infrastructure technologies. The company was founded on December 30, 2024 and is headquartered in New York, NY.

SharonAI Holdings Inc. - Ordinary Shares - Class A

SharonAI is trending following the announcement of a massive multi-year AI infrastructure contract, fueling intense community speculation about its low-float potential to trigger a significant short squeeze.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is trending as investors gear up for the upcoming 10-K filing and earnings report, with the community actively debating the company's debt reduction progress and the potential valuation impact of its significant holdings in Applied Digital and B. Riley Wealth. While sentiment is divided between bulls anticipating a re-rating on stronger balance sheet optics and skeptics concerned about lingering leverage and lack of clear guidance, the stock remains a focal point for those tracking a high-stakes turnaround play.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors digest the commercial launch of Yartemlea and monitor the potential for near-term milestone payments from its multi-billion dollar partnership with Novo Nordisk. Community discussion remains heavily focused on the stock's significant short interest, with many retail shareholders expressing frustration over stagnant price action while others remain bullish on the long-term value of the company's pipeline and pending European regulatory developments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

QXO names tech veteran Val Liborski as new CTO

Investing.com -- QXO Inc (NYSE:QXO) announced Wednesday the appointment of Val Liborski as chief technology officer (CTO), effective from April 21, 2025. Liborski, a global tech veteran, previously held the same role at Yahoo and HelloFresh (OTC:HLFFF). He also led engineering and product management at Amazon (NASDAQ:AMZN) Web Services and later managed the technology for Amazon’s consumer business expansion in Europe. Early in his career, Liborski held senior engineering positions at Microsoft (NASDAQ:MSFT), where he developed large-scale data systems for Bing and advanced AI-driven advertising platforms.

QXO strikes $11 bln deal for Beacon Roofing- WSJ

Investing.com-- QXO Inc (NYSE:QXO) has entered a deal to acquire  Beacon Roofing  Supply Inc (NASDAQ:BECN) at a slightly higher price than earlier offered, the Wall Street Journal reported on Wednesday citing comments from executives. 

Shares of Beacon Roofing Supply (BECN) rose more than 2% in after hours trading on Monday following announcement from QXO that it is extending its all-cash tender buyout offer.QXO, a building-products distribution company headed by billionaire Brad Jacobs, has also secured $830 million in a fresh equity raise in connection to the buyout, WSJ reported.&nbsp;The closing of the equity raise is contingent upon the closure of the outstanding all-cash tender offer that was scheduled to expire on Friday. The extension gives it until March 18 for requisite approvals.According to a QXO statement, about 11,293,572 shares have been validly tendered and not withdrawn, representing about 18.34% of the issued and outstanding shares of Beacon Roofing.IQXO had launched a tender offer to purchase all outstanding shares of Beacon for $124.25 per share in cash for about $11 billion, which represented a 37% premium to Beacon's 90-day unaffected volume-weighted average price per share as of Nov. 15, 2024.Beacon’s board has repeatedly rejected the bid contending it wasn’t in the best interest of its shareholders.QXO has previously said it had received clearance in both the U.S. and Canada for the transaction, along with plans to nominate independent directors at the company’s forthcoming annual investor meeting.Last month, Stifel downgraded Beacon to ‘Hold’ from ‘Buy’ with a price target of $122.55, down from $131 after its board rejected the $124.25 per share tender offer.According to the analyst firm, its scenario analysis favors QXO successfully acquiring Beacon at $124.25 per share.Beacon distributes specialty building products, including roofing materials and complementary products, such as siding and waterproofing.Sentiment on Stocktwits ended Monday on a ‘bullish’ note. Message volume remained in the ‘high’ zone.<figure class="image"><img style="aspect-ratio:1306/312;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_03_18_at_1_33_20_PM_png_4887984948.webp" alt="Screenshot 2025-03-18 at 1.33.20 PM.png" width="1306" height="312"><figcaption>BECN sentiment meter and message volume on March 18 as of 1 am ET.</figcaption></figure>Beacon stock is up 18% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Beacon Roofing Supply Stock Rises After QXO Extends Deadline For $11B Offer: Retail Stays Bullish

QXO has also secured $830 million in a fresh equity raise in connection to the offer, WSJ reported.

Equity

QXO CEO outlines employee-first approach in potential Beacon takeover

QXO Inc.'s (NYSE:QXO) CEO, Brad Jacobs, addressed Beacon (NASDAQ:BECN) employees directly in an open letter as the company continues its efforts to acquire the building products distributor. Jacobs emphasized respect for Beacon's workforce and outlined a commitment to prioritizing employee input should the takeover succeed.

QXO's Jacobs calls Beacon's claims 'a head-scratcher' as they continue pursuit

On Wednesday, QXO Inc. (NYSE:QXO) CEO and Chairman Brad Jacobs addressed what he described as misleading and inaccurate claims made by takeover target Beacon (NASDAQ:BECN) in a recent press release. The response follows QXO's second extension of its tender offer for Beacon at $124.25 per share in cash.

Shares of Beacon Roofing Supply ($BECN) were in the spotlight on Wednesday after technology solutions company QXO Inc. said it had obtained antitrust clearance for its $11 billion takeover of the former, lifting retail sentiment.QXO said it had received clearance in both the U.S. and Canada that would pave the way for the transaction to close quickly. &nbsp;It also plans to nominate independent directors at the company’s forthcoming annual investor meeting.“With committed financing in place and these necessary regulatory approvals secured, QXO is prepared to complete this acquisition and deliver immediate, compelling value to Beacon shareholders,” said Brad Jacobs, chairman and CEO of QXO. "Beacon should remove its shareholder-unfriendly poison pill so shareholders can benefit from our premium all-cash offer."In a statement, Beacon said its board’s makeup already consists of “highly qualified directors” and that QXO’s director nominations “appear to be an attempt to pressure Beacon’s board into accepting an unchanged offer price that significantly undervalues Beacon’s prospects for growth and value creation”It reiterated it is open to considering all opportunities to maximize shareholder value.Sentiment on Stocktwits turned ‘extremely bullish’ from ‘bullish’ a week ago with some users expressing concern if the offer would get rescinded after multiple rejections by Beacon. While message volumes jumped into the ‘extremely high’ zone from ‘low.’<figure class="image"><img style="aspect-ratio:1324/302;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_02_13_at_3_20_04_PM_8fbf41a9a5.png" alt="Screenshot 2025-02-13 at 3.20.04 PM.png" width="1324" height="302"><figcaption>BECN sentiment meter and message volumes on Feb 12</figcaption></figure><stembedurl>https://stocktwits.com/Bassfisher89/message/603915003</stembedurl>Recently, Stifel downgraded Beacon to ‘Hold’ from ‘Buy’ with a price target of $122.55, down from $131 after its board rejected the $124.25 per share tender offer, Fly.com reported. According to the analyst firm, its scenario analysis favors QXO successfully acquiring Beacon at $124.25 per share. In January, QXO commenced a tender offer to purchase all outstanding shares of Beacon for $124.25 per share in cash for an aggregate enterprise value of approximately $11 billion, representing a 37% premium to Beacon's 90-day unaffected volume-weighted average price per share as of November 15, 2024. Beacon distributes specialty building products, including roofing materials and complementary products, such as siding and waterproofing. It operates over 580 branches throughout all 50 states in the U.S. and seven provinces in Canada. For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image. Source: Getty Images

Beacon Roofing's Stock In Focus As QXO's Buyout Offer Gets Regulatory Nod: Retail Sentiment Brightens

Sentiment on Stocktwits turned ‘extremely bullish’ from ‘bullish’ a week ago 

Shares of Beacon Roofing Supply ($BECN) rose about 1.29% on Friday even as the company received a downgrade from analyst firm Stifel, following another rejection of a $11 billion buyout offer from technology solutions company QXO Inc., but retail sentiment remained neutral.Stifel downgraded Beacon to ‘Hold’ from ‘Buy’ with a price target of $122.55, down from $131 after its board yet again rejected the $124.25 per share tender offer, Fly.com reported.According to the &nbsp;analyst firm, its scenario analysis favors QXO successfully acquiring Beacon at $124.25 per share, and even though the rejection was anticipated, any upside of a strategic acquirer has become "significantly less likely," added the report. &nbsp;Additionally, the lack of a formal process against QXO's offer "significantly reduces" the chances of a takeover.Beacon on Thursday said that QXO has failed to improve its first and only proposal “which the board determined significantly undervalues the company and our prospects for growth and value creation.”Responding to the rejection, QXO urged the company to let shareholders decide, "Beacon's filing shows no indication of an actionable third-party alternative. We have made a very compelling offer, and Beacon should let its shareholders decide what is in their best interest."QXO is owned by billionaire Brad Jacobs who has invested previously in logistics companies. QXO had secured committed financing for the deal, QXO has stated previously.Beacon previously rejected the $11 billion takeover bid from QXO Inc. after which the latter was seeking to take the offer to Beacon shareholders.Sentiment on Stocktwits remained ‘neutral’ while message volumes stayed in the ‘low’ zone.<figure class="image"><img style="aspect-ratio:1294/286;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_02_07_at_1_12_02_PM_ae0e266501.png" alt="Screenshot 2025-02-07 at 1.12.02 PM.png" width="1294" height="286"><figcaption>BECN sentiment meter and message volumes on Feb 6</figcaption></figure> <stembedurl>https://stocktwits.com/asbpame/message/603024533</stembedurl>Beacon distributes specialty building products, including roofing materials and complementary products, such as siding and waterproofing. It operates over 580 branches throughout all 50 states in the U.S. and seven provinces in Canada. For updates and corrections, email newsroom[at]stocktwits[dot]com.

Beacon Roofing Stock In Focus After Analyst Downgrade Following Rejection Of QXO Buyout Offer: Retail’s Divided 

Stifel downgraded Beacon to ‘Hold’ from ‘Buy’ with a price target of $122.55, down from $131

Beacon adopts poison pill

Investing.com -- Beacon Roofing Supply announced on Tuesday that its board of directors has adopted a limited-duration stockholder rights agreement, often referred to as a "poison pill," in response to a hostile takeover bid from QXO, Inc. 

Shares of Beacon Roofing Supply ($BECN) rose about 1.62% on Friday as the company reportedly began looking for potential buyers, with retail sentiment staying neutral. Earlier this month, Beacon had rejected an $11 billion takeover bid from QXO Inc. ($QXO), which is now considering to reportedly taking the bid directly to its shareholders, WSJ <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/business/deals/building-products-distributor-qxo-launching-hostile-bid-for-beacon-de024410">reported.</a> WSJ reported technology solutions company QXO plans to launch a bid as soon as Monday at the same price it offered earlier. QXO had offered to buy all outstanding shares of Beacon for $124.25 per share in cash. In an earlier statement, Beacon had said the proposal from AXO had “significantly undervalued the company” and wasn’t in the best interest of its shareholders and the company. Sentiment on Stocktwits was ‘neutral’ while message volumes were in the ‘low’ zone.<figure class="image"><img style="aspect-ratio:1292/308;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_01_27_at_7_18_06_AM_e333e3cb76.png" alt="Screenshot 2025-01-27 at 7.18.06 AM.png" width="1292" height="308"><figcaption>BECN sentiment meter and message volumes on Jan 26 as of 8:57 pm ET</figcaption></figure>Virginia-based Beacon had been in talks with QXO since November when it first received the offer.QXO has secured the committed financing for the deal and has also nominated directors to Beacon’s board. QXO is owned by billionaire Brad Jacobs who has invested previously in logistics companies.Stifel analyst W. Andrew Carter raised the firm's price target to $131 from $115 with a ‘Buy’ rating, Fly.com reported. The firm sees Beacon buyout as "highly likely" following QXO's formal $124.25 per share offer, which was rejected. Beacon distributes specialty building products, including roofing materials and complementary products, such as siding and waterproofing. It operates over 580 branches throughout all 50 states in the U.S. and seven provinces in Canada.For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp; &nbsp; &nbsp;&nbsp;

Beacon Roofing Stock Rises After Company Starts Looking For Buyers: Retail Neutral

Beacon rejected an $11 billion takeover bid from QXO Inc. ($QXO), which is now considering to reportedly taking the bid directly to its shareholders

QXO planning to launch hostile bid for Beacon Roofing- WSJ

Investing.com--  Building products distributor QXO Inc (NYSE:QXO) is planning to launch a hostile bid for  Beacon Roofing  Supply Inc (NASDAQ:BECN) by approaching shareholders directly, the Wall Street Journal reported on Sunday.

Beacon Roofing Supply, Inc. engages in the distribution of residential and non-residential roofing materials. It also distributes complementary building products including siding, windows, specialty exterior building products, insulation, and waterproofing systems for building exteriors. The company was founded on August 22, 1997 and is headquartered in Herndon, VA.

Beacon Roofing Supply Inc - Ordinary Shares - Class A

Thematic ETFs

Prediction Markets

OpenClaw & Agentic-Directed Trading

Tokenization

Recognizing the tool or mechanism that redefined how we trade. From prediction markets to next-gen tech, this award honors the innovation that pushed the boundaries of access and efficiency in modern finance.

BECN
Beacon Roofing Supply Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BECN News

BECNBeacon Roofing Supply Inc - Ordinary Shares - Class A